NeoGenomics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $294.0M | $988.3M | $228.7M |
| FY2021 | $761.5M | $1.87B | $316.8M |
| FY2022 | $742.0M | $1.74B | $263.2M |
| FY2023 | $739.7M | $1.68B | $342.5M |
| FY2024 | $735.7M | $1.64B | $367.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $294.0M | $988.3M | $228.7M |
| FY2021 | $761.5M | $1.87B | $316.8M |
| FY2022 | $742.0M | $1.74B | $263.2M |
| FY2023 | $739.7M | $1.68B | $342.5M |
| FY2024 | $735.7M | $1.64B | $367.0M |